Citations (112)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (33)
David J Kopsky, Karolina M Szadek, Patrick Schober, Alexander F J E Vrancken & Monique A H Steegers. (2022) Study Design Characteristics and Endpoints for Enriched Enrollment Randomized Withdrawal Trials for Chronic Pain Patients: A Systematic Review. Journal of Pain Research 15, pages 479-496.
Read now
Read now
Filip Jovanovic, Iulia Pirvulescu, Emilija Knezevic, Kenneth D. Candido & Nebojsa Nick Knezevic. (2021) Comparative safety review of current treatment options for chronic low back pain and unmet needs: a narrative review. Expert Opinion on Drug Safety 20:9, pages 1005-1033.
Read now
Read now
Filippo Migliorini, Nicola Maffulli, Alice Baroncini, Jörg Eschweiler, Markus Tingart & Valentin Quack. (2021) Opioids for chronic low back pain management: a Bayesian network meta-analysis. Expert Review of Clinical Pharmacology 14:5, pages 635-641.
Read now
Read now
Filippo Migliorini, Nicola Maffulli, Jörg Eschweiler, Marcel Betsch, Giovanni Catalano, Arne Driessen, Markus Tingart & Alice Baroncini. (2021) The pharmacological management of chronic lower back pain. Expert Opinion on Pharmacotherapy 22:1, pages 109-119.
Read now
Read now
R. Freynhagen, C. Elling, T. Radic, M. Sohns, H. Liedgens, D. James, R. McCool & M. Edwards. (2021) Safety of tapentadol compared with other opioids in chronic pain treatment: network meta-analysis of randomized controlled and withdrawal trials. Current Medical Research and Opinion 37:1, pages 89-100.
Read now
Read now
Jeffrey Gudin, Andrew G Kaufman & Samyadev Datta. (2020) Are Opioids Needed to Treat Chronic Low Back Pain? A Review of Treatment Options and Analgesics in Development. Journal of Pain Research 13, pages 1007-1022.
Read now
Read now
Joseph V Pergolizzi Jr & Robert B Raffa. (2019) Safety And Efficacy Of The Unique Opioid Buprenorphine For The Treatment Of Chronic Pain. Journal of Pain Research 12, pages 3299-3317.
Read now
Read now
Diana S Meske, Oluwadolapo D Lawal, Harrison Elder, Valerie Langberg, Florence Paillard & Nathaniel Katz. (2018) Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trials. Journal of Pain Research 11, pages 923-934.
Read now
Read now
Richard L. Rauck, Jeffrey Potts, Qinfang Xiang, Evan Tzanis & Andrew Finn. (2016) Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain. Postgraduate Medicine 128:1, pages 1-11.
Read now
Read now
Martin E Hale, Charles Laudadio, Ronghua Yang, Arvind Narayana & Richard Malamut. (2015) Efficacy and tolerability of a hydrocodone extended-release tablet formulated with abuse-deterrence technology for the treatment of moderate-to-severe chronic pain in patients with osteoarthritis or low back pain. Journal of Pain Research 8, pages 623-636.
Read now
Read now
Tsutomu Arai, Yuji Kashimoto, Yoshifumi Ukyo, Yushin Tominaga & Keiichiro Imanaka. (2015) Two placebo-controlled, randomized withdrawal studies to evaluate the fentanyl 1 day patch in opioid-naïve patients with chronic pain. Current Medical Research and Opinion 31:12, pages 2207-2218.
Read now
Read now
Warren Wen, Steve Sitar, Shau Yu Lynch, Ellie He & Steven R Ripa. (2015) A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with uncontrolled moderate to severe chronic low back pain. Expert Opinion on Pharmacotherapy 16:11, pages 1593-1606.
Read now
Read now
Nalini Sehgal, James Colson & Howard S Smith. (2013) Chronic pain treatment with opioid analgesics: benefits versus harms of long-term therapy. Expert Review of Neurotherapeutics 13:11, pages 1201-1220.
Read now
Read now
John H. Peniston. (2012) A Review of Pharmacotherapy for Chronic Low Back Pain with Considerations for Sports Medicine. The Physician and Sportsmedicine 40:4, pages 21-32.
Read now
Read now
John H. Peniston, Xiaojun Hu, Susan L. Potts, Matthew S. Wieman & Dennis C. Turk. (2012) Tolerability of Concomitant Use of Selective Serotonin Reuptake Inhibitors or Serotonin-Norepinephrine Reuptake Inhibitors and Oxymorphone Extended Release. Postgraduate Medicine 124:2, pages 114-122.
Read now
Read now
Noam Y. Kirson, Alan G. White, Howard G. Birnbaum, Matt Schiller, Tracy Waldman, Kirsten Peterson, Rami H. Ben-Joseph, Todd Berner & Kent H. Summers. (2012) Direct and indirect costs of patients treated with extended-release oxymorphone HCl or controlled-release oxycodone HCl. Journal of Medical Economics 15:1, pages 87-95.
Read now
Read now
James Brown, Beatrice Setnik, Keung Lee, Jody M Cleveland, Carl L Roland, Linda Wase & Lynn Webster. (2011) Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting. Journal of Pain Research 4, pages 373-384.
Read now
Read now
Lynn R. Webster, Randall Brewer, David Morris, Jody M. Cleveland & Beatrice Setnik. (2011) Opioid Titration and Conversion in Patients Receiving Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules. Postgraduate Medicine 123:5, pages 155-164.
Read now
Read now
Carl L. Roland, Beatrice Setnik, Jody M. Cleveland & David A. Brown. (2011) Clinical Outcomes during Opioid Titration following Initiation with or Conversion to Remoxy®, an Extended-Release Formulation of Oxycodone. Postgraduate Medicine 123:4, pages 148-159.
Read now
Read now
G.E. Bekkering, K. Soares-Weiser, K. Reid, A.G. Kessels, A. Dahan, R.D. Treede & J. Kleijnen. (2011) Can morphine still be considered to be the standard for treating chronic pain? A systematic review including pair-wise and network meta-analyses. Current Medical Research and Opinion 27:7, pages 1477-1491.
Read now
Read now
Howard S Smith. (2011) Morphine sulfate and naltrexone hydrochloride extended release capsules for the management of chronic, moderate-to-severe pain, while reducing morphine-induced subjective effects upon tampering by crushing. Expert Opinion on Pharmacotherapy 12:7, pages 1111-1125.
Read now
Read now
S.R. Nalamachu, A. Narayana & L. Janka. (2011) Long-term dosing, safety, and tolerability of fentanyl buccal tablet in the management of noncancer-related breakthrough pain in opioid-tolerant patients. Current Medical Research and Opinion 27:4, pages 751-760.
Read now
Read now
Irma H Benedek, Janet Jobes, Qinfang Xiang & William D Fiske. (2011) Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release. Drug Design, Development and Therapy 5, pages 455-463.
Read now
Read now
Sherwyn Schwartz, Mila Etropolski, Douglas Y. Shapiro, Akiko Okamoto, Robert Lange, Juergen Haeussler & Christine Rauschkolb. (2011) Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial. Current Medical Research and Opinion 27:1, pages 151-162.
Read now
Read now
Bart Morlion. (2011) Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components. Current Medical Research and Opinion 27:1, pages 11-33.
Read now
Read now
Roy D. Altman & Howard S. Smith. (2010) Opioid Therapy for Osteoarthritis and Chronic Low Back Pain. Postgraduate Medicine 122:6, pages 87-97.
Read now
Read now
Robert Buynak, Douglas Y Shapiro, Akiko Okamoto, Ilse Van Hove, Christine Rauschkolb, Achim Steup, Bernd Lange, Claudia Lange & Mila Etropolski. (2010) Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study. Expert Opinion on Pharmacotherapy 11:11, pages 1787-1804.
Read now
Read now
John H. Peniston, Qinfang Xiang & Errol M. Gould. (2010) Factors affecting acceptability of titrated oxymorphone extended release in chronic low back pain – an individual patient analysis. Current Medical Research and Opinion 26:8, pages 1861-1871.
Read now
Read now
Nathaniel Katz, Martin Hale, David Morris & Joseph Stauffer. (2010) Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules in Patients with Chronic Osteoarthritis Pain. Postgraduate Medicine 122:4, pages 112-128.
Read now
Read now
Joseph V Pergolizzi$suffix/text()$suffix/text(), Robert B Raffa & Errol Gould. (2009) Considerations on the use of oxymorphone in geriatric patients. Expert Opinion on Drug Safety 8:5, pages 603-613.
Read now
Read now
Jun Shao, DavidC. Jordan & YiliL. Pritchett. (2009) Baseline Observation Carry Forward: Reasoning, Properties, and Practical Issues. Journal of Biopharmaceutical Statistics 19:4, pages 672-684.
Read now
Read now
Paul Sloan. (2008) Review of oral oxymorphone in the management of pain. Therapeutics and Clinical Risk Management 4:4, pages 777-787.
Read now
Read now
Alan K Matsumoto. (2007) Oral extended-release oxymorphone: a new choice for chronic pain relief. Expert Opinion on Pharmacotherapy 8:10, pages 1515-1527.
Read now
Read now
Articles from other publishers (79)
Filippo Migliorini, Raju Vaishya, Gaetano Pappalardo, Marco Schneider, Andreas Bell & Nicola Maffulli. (2023) Between guidelines and clinical trials: evidence-based advice on the pharmacological management of non-specific chronic low back pain. BMC Musculoskeletal Disorders 24:1.
Crossref
Crossref
Jae-Young Hong, Kwang-Sup Song, Jae Hwan Cho, Jae Hyup Lee & Nack Hwan Kim. (2022) An Updated Overview of Low Back Pain Management. Asian Spine Journal 16:6, pages 968-982.
Crossref
Crossref
Stephen E Nadeau & Richard A Lawhern. (2022) Management of chronic non-cancer pain: a framework. Pain Management 12:6, pages 751-777.
Crossref
Crossref
Alice Bruneau, Clarice Poirier, Mélanie Bérubé, Aline Boulanger, Céline Gélinas, Line Guénette, Anaïs Lacasse, David Lussier, Yannick Tousignant-Laflamme, M. Gabrielle Pagé & Marc O. Martel. (2022) French-Canadian Translation and Cultural Adaptation of the Clinical Opiate Withdrawal Scale: The COWS-FC. The Canadian Journal of Psychiatry 67:9, pages 701-711.
Crossref
Crossref
Atefeh Noori, Behnam Sadeghirad, Li Wang, Reed A.C. Siemieniuk, Mostafa Shokoohi, Elena Kum, Mark Jeddi, Luis Montoya, Patrick J. Hong, Edward Zhou, Rachel J. Couban, David N. Juurlink, Lehana Thabane, Mohit Bhandari, Gordon H. Guyatt & Jason W. Busse. (2022) Comparative benefits and harms of individual opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised trials. British Journal of Anaesthesia 129:3, pages 394-406.
Crossref
Crossref
Edris Nury, Christine Schmucker, Blin Nagavci, Edith Motschall, Kai Nitschke, Erika Schulte, Odette Wegwarth & Joerg J. Meerpohl. (2022) Efficacy and safety of strong opioids for chronic noncancer pain and chronic low back pain: a systematic review and meta-analyses. Pain 163:4, pages 610-636.
Crossref
Crossref
Osamu Shirado, Yoshiyasu Arai, Tetsuhiro Iguchi, Shiro Imagama, Mamoru Kawakami, Takuya Nikaido, Tadanori Ogata, Sumihisa Orita, Daisuke Sakai, Kimiaki Sato, Masahiko Takahata, Katsushi Takeshita, Takashi Tsuji, Kei Ando, Yoshiyasu Arai, Teruaki Endo, Hironari Fukuda, Masafumi Goto, Hiroshi Hashidume, Masayuki Hino, Yohei Ide, Tetsuhiro Iguchi, Shiro Imagama, Hirokazu Inoue, Taro Inoue, Yuyu Ishimoto, Kenyu Ito, Sadayuki Ito, Masumi Iwabuchi, Shoji Iwahashi, Hiroshi Iwasaki, Ryohei Kagotani, Shunsuke Kanbara, Kinshi Kato, Mamoru Kawakami, Atsushi Kimura, Tomoko Kitagawa, Hiroshi Kobayashi, Kazuyoshi Kobayashi, Jun Komatsu, Hiroyuki Koshimizu, Masaaki Machino, Tsunemasa Matsubara, Yu Matsukura, Akihito Minamide, Masakazu Minetama, Kenji Mizokami, Tadao Morino, Masayoshi Morozumi, Keiji Nagata, Ichiro Nakae, Masafumi Nakagawa, Yukihiro Nakagawa, Takuya Nikaido, Tadanori Ogata, Sumihisa Orita, Kyotaro Ota, Daisuke Sakai, Kenichiro Sakai, Rikiya Saruwatari, Shinichi Sasaki, Kimiaki Sato, Takahiro Shimazaki, Osamu Shirado, Yasuyuki Shiraishi, Masahiko Takahata, Masanari Takami, Katsushi Takeshita, Satoshi Tanaka, Masatoshi Teraguchi, Ryoji Tominaga, Masaki Tomori, Ichiro Torigoe, Takashi Tsuji, Mikito Tsushima, Shunji Tsutsui, Kazuyuki Watanabe, Hiroshi Yamada, Kei Yamada, Hidetoshi Yamaguchi, Kimiaki Yokosuka, Takanori Yoshida, Tatsuhiro Yoshida, Masato Yuasa & Yasutsugu Yugawa. (2022) Formulation of Japanese Orthopaedic Association (JOA) clinical practice guideline for the management of low back pain- the revised 2019 edition. Journal of Orthopaedic Science 27:1, pages 3-30.
Crossref
Crossref
Stephen E. Nadeau, Jeffrey K. Wu & Richard A. Lawhern. (2021) Opioids and Chronic Pain: An Analytic Review of the Clinical Evidence. Frontiers in Pain Research 2.
Crossref
Crossref
Hannah-Rose Tucker, Katie Scaff, Tess McCloud, Kimberly Carlomagno, Kathleen Daly, Alessandra Garcia & Chad E Cook. (2020) Harms and benefits of opioids for management of non-surgical acute and chronic low back pain: a systematic review. British Journal of Sports Medicine 54:11, pages 664-664.
Crossref
Crossref
Frank Petzke, Petra Klose, Patrick Welsch, Claudia Sommer & Winfried Häuser. (2019) Opioids for chronic low back pain: An updated systematic review and meta‐analysis of efficacy, tolerability and safety in randomized placebo‐controlled studies of at least 4 weeks of double‐blind duration. European Journal of Pain 24:3, pages 497-517.
Crossref
Crossref
David A. Edwards, Traci L. Hedrick, Jennifer Jayaram, Charles Argoff, Padma Gulur, Stefan D. Holubar, Tong J. Gan, Michael G. Mythen, Timothy E. Miller, Andrew D. Shaw, Julie K. M. ThackerMatthew D. McEvoy. (2019) American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Perioperative Management of Patients on Preoperative Opioid Therapy. Anesthesia & Analgesia 129:2, pages 553-566.
Crossref
Crossref
Jason W. Busse, Li Wang, Mostafa Kamaleldin, Samantha Craigie, John J. Riva, Luis Montoya, Sohail M. Mulla, Luciane C. Lopes, Nicole Vogel, Eric Chen, Karin Kirmayr, Kyle De Oliveira, Lori Olivieri, Alka Kaushal, Luis E. Chaparro, Inna Oyberman, Arnav Agarwal, Rachel Couban, Ludwig Tsoi, Tommy Lam, Per Olav Vandvik, Sandy Hsu, Malgorzata M. Bala, Stefan SchandelmaierAnne Scheidecker, Shanil Ebrahim, Vahid Ashoorion, Yasir Rehman, Patrick J. Hong, Stephanie Ross, Bradley C. Johnston, Regina KunzXin Sun, Norman Buckley, Daniel I. Sessler & Gordon H. Guyatt. (2018) Opioids for Chronic Noncancer Pain. JAMA 320:23, pages 2448.
Crossref
Crossref
Jae-Young Hong, Kwang-Sup Song, Jae Hwan Cho & Jae Hyup Lee. (2017) An Updated Overview of Low Back Pain Management in Primary Care. Asian Spine Journal 11:4, pages 653-660.
Crossref
Crossref
Jonah Campbell & Nicholas B King. (2017) “Unsettling circularity”: Clinical trial enrichment and the evidentiary politics of chronic pain. BioSocieties 12:2, pages 191-216.
Crossref
Crossref
Ji Hoon Yoo, Anna Borsodi, Géza Tóth, Sándor Benyhe, Robert Gaspar, Audrey Matifas, Brigitte L. Kieffer, Athanasios Metaxas, Ian Kitchen & Alexis Bailey. (2017) Characterization of [3H] oxymorphone binding sites in mouse brain: Quantitative autoradiography in opioid receptor knockout mice. Neuroscience Letters 643, pages 16-21.
Crossref
Crossref
Joseph Gimbel, Egilius L.H. Spierings, Nathaniel Katz, Qinfang Xiang, Evan Tzanis & Andrew Finn. (2016) Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal study. Pain 157:11, pages 2517-2526.
Crossref
Crossref
Christina Abdel Shaheed, Chris G. Maher, Kylie A. Williams, Richard Day & Andrew J. McLachlan. (2016) Efficacy, Tolerability, and Dose-Dependent Effects of Opioid Analgesics for Low Back Pain. JAMA Internal Medicine 176:7, pages 958.
Crossref
Crossref
Xavier Moisset, Anne-Priscille Trouvin, Viet-Thi Tran, Nicolas Authier, Pascale Vergne-Salle, Virginie Piano & Valeria Martinez. (2016) Utilisation des opioïdes forts dans la douleur chronique non cancéreuse chez l’adulte. Recommandations françaises de bonne pratique clinique par consensus formalisé (SFETD). Douleurs : Evaluation - Diagnostic - Traitement 17:3, pages 145-160.
Crossref
Crossref
Xavier Moisset, Anne-Priscille Trouvin, Viet-Thi Tran, Nicolas Authier, Pascale Vergne-Salle, Virginie Piano & Valeria Martinez. (2016) Utilisation des opio?des forts dans la douleur chronique non canc?reuse chez l?adulte. Recommandations fran?aises de bonne pratique clinique par consensus formalis? (SFETD). La Presse M?dicale 45:4, pages 447-462.
Crossref
Crossref
Kenneth D. Candido, Joseph Chiweshe, Utchariya Anantamongkol & Nebojsa Nick Knezevic. (2016) Can Chronic Pain Patients Be Adequately Treated Using Generic Pain Medications to the Exclusion of Brand-Name Ones?. American Journal of Therapeutics 23:2, pages e489-e497.
Crossref
Crossref
Robert Froud, Tom Bjørkli, Philip Bright, Dévan Rajendran, Rachelle Buchbinder, Martin Underwood, David Evans & Sandra Eldridge. (2015) The effect of journal impact factor, reporting conflicts, and reporting funding sources, on standardized effect sizes in back pain trials: a systematic review and meta-regression. BMC Musculoskeletal Disorders 16:1.
Crossref
Crossref
Nathaniel Katz, Ernest A. Kopecky, Melinda O'Connor, Robert H. Brown & Alison B. Fleming. (2015) A phase 3, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability, and efficacy study of Xtampza ER in patients with moderate-to-severe chronic low back pain. Pain 156:12, pages 2458-2467.
Crossref
Crossref
R. Andrew Moore, Philip J. Wiffen, Christopher Eccleston, Sheena Derry, Ralf Baron, Rae F. Bell, Andrea D. Furlan, Ian Gilron, Simon Haroutounian, Nathaniel P. Katz, Arthur G. Lipman, Stephen Morley, Paul M. Peloso, Steve N. Quessy, Kate Seers, Scott A. Strassels & Sebastian Straube. (2015) Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain. Pain 156:8, pages 1382-1395.
Crossref
Crossref
Benjamin G. Rohe, Ronald Carter, William R. Thompson, Randall L. Duncan & Carlton R. Cooper. (2015) Experimental Integrative Muscular Movement Technique Enhances Cervical Range of Motion in Patients with Chronic Neck Pain: A Pilot Study. The Journal of Alternative and Complementary Medicine 21:4, pages 223-228.
Crossref
Crossref
Richard L. Rauck. (2015) Response to Letter by Dr. Engel. Pain Medicine 16:2, pages 404.2-406.
Crossref
Crossref
F. Petzke, P. Welsch, P. Klose, R. Schaefert, C. Sommer & W. Häuser. (2014) Opioide bei chronischem KreuzschmerzOpioids in chronic low back pain. Der Schmerz 29:1, pages 60-72.
Crossref
Crossref
Richard L. Rauck, Srinivas Nalamachu, James E. Wild, George S. Walker, Cynthia Y. Robinson, Charles S. Davis & Stephen J. Farr. (2014) Single-Entity Hydrocodone Extended-Release Capsules in Opioid-Tolerant Subjects with Moderate-to-Severe Chronic Low Back Pain: A Randomized Double-Blind, Placebo-Controlled Study. Pain Medicine 15:6, pages 975-985.
Crossref
Crossref
Luis Enrique Chaparro, Andrea D. Furlan, Amol Deshpande, Angela Mailis-Gagnon, Steven Atlas & Dennis C. Turk. (2014) Opioids Compared With Placebo or Other Treatments for Chronic Low Back Pain. Spine 39:7, pages 556-563.
Crossref
Crossref
Nicholas Henschke, Annefloor van Enst, Robert Froud & Raymond WG Ostelo. (2014) Responder analyses in randomised controlled trials for chronic low back pain: an overview of currently used methods. European Spine Journal 23:4, pages 772-778.
Crossref
Crossref
Edward Michna, Wendy Y. Cheng, Caroline Korves, Howard Birnbaum, Ryan Andrews, Zhou Zhou, Ashish V. Joshi, David Schaaf, Jack Mardekian & Mei Sheng. (2014) Systematic Literature Review and Meta-Analysis of the Efficacy and Safety of Prescription Opioids, Including Abuse-Deterrent Formulations, in Non-Cancer Pain Management. Pain Medicine 15:1, pages 79-92.
Crossref
Crossref
Hélène Cawston, Alison Davie, Marie-Ange Paget, Vladimir Skljarevski & Michael Happich. (2013) Efficacy of duloxetine versus alternative oral therapies: an indirect comparison of randomised clinical trials in chronic low back pain. European Spine Journal 22:9, pages 1996-2009.
Crossref
Crossref
Luis Enrique Chaparro, Andrea D Furlan, Amol Deshpande, Angela Mailis-Gagnon, Steven Atlas & Dennis C Turk. (2013) Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Ronald Wielage, Megha Bansal, Kinsley Wilson, Robert Klein & Michael Happich. (2013) Cost-Effectiveness of Duloxetine in Chronic Low Back Pain. Spine 38:11, pages 936-946.
Crossref
Crossref
Mark P. Jensen, Xiaojun Hu, Susan L. Potts & Errol M. Gould. (2013) Single vs composite measures of pain intensity: Relative sensitivity for detecting treatment effects. Pain 154:4, pages 534-538.
Crossref
Crossref
M.W. van Tulder & B.W. KoesM.W. van Tulder & B.W. Koes. 2013. Evidence-based handelen bij lage rugpijn. Evidence-based handelen bij lage rugpijn
101
137
.
Pascale Vergne-Salle, Françoise Laroche, Anne Bera-Louville, Marc Marty, Rose-Marie Javier & Serge Perrot. (2012) Les opioïdes forts dans les douleurs ostéo-articulaires non cancéreuses : revue de la littérature et recommandations pour la pratique clinique : « Les recommandations de Limoges 2010 ». Douleurs : Evaluation - Diagnostic - Traitement 13:6, pages 259-275.
Crossref
Crossref
Beth D. Darnall, Brett R. Stacey & Roger Chou. (2012) Medical and Psychological Risks and Consequences of Long-Term Opioid Therapy in Women. Pain Medicine 13:9, pages 1181-1211.
Crossref
Crossref
Glenn T. Clark & Steven H. Richeimer. 2012. Orofacial Pain. Orofacial Pain
66
83
.
William D. Fiske, Janet Jobes, Qinfang Xiang, Sou-Chan Chang & Irma H. Benedek. (2012) The Effects of Ethanol on the Bioavailability of Oxymorphone Extended-Release Tablets and Oxymorphone Crush-Resistant Extended-Release Tablets. The Journal of Pain 13:1, pages 90-99.
Crossref
Crossref
Jerome Schofferman & Daniel Mazanec. 2012. Evidence-Based Management of Low Back Pain. Evidence-Based Management of Low Back Pain
154
170
.
Alexander Brack, Heike L. Rittner & Christoph Stein. (2011) Immunosuppressive Effects of Opioids—Clinical Relevance. Journal of Neuroimmune Pharmacology 6:4, pages 490-502.
Crossref
Crossref
Gary Bouloux. (2011) Response to Dr Howard Smith. Journal of Oral and Maxillofacial Surgery 69:11, pages 2690.
Crossref
Crossref
Howard S. Smith. (2011) Response to Bouloux: Use of Opioids in Long-Term Management of Temporomandibular Joint Dysfunction. Journal of Oral and Maxillofacial Surgery 69:11, pages 2689-2690.
Crossref
Crossref
Andrew P. White, Paul M. Arnold, Daniel C. Norvell, Erika Ecker & Michael G. Fehlings. (2011) Pharmacologic Management of Chronic Low Back Pain. Spine 36, pages S131-S143.
Crossref
Crossref
David J. Hewitt, Tony W. Ho, Bradley Galer, Miroslav Backonja, Paul Markovitz, Arnold Gammaitoni, David Michelson, James Bolognese, Achilles Alon, Elizabeth Rosenberg, Gary Herman & Hao Wang. (2011) Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic pain. Pain 152:3, pages 514-521.
Crossref
Crossref
T. Kuijpers, M. van Middelkoop, S. M. Rubinstein, R. Ostelo, A. Verhagen, B. W. Koes & M. W. van Tulder. (2010) A systematic review on the effectiveness of pharmacological interventions for chronic non-specific low-back pain. European Spine Journal 20:1, pages 40-50.
Crossref
Crossref
Sherwyn Schwartz, Mila Etropolski, Douglas Y. Shapiro, Akiko Okamoto, Robert Lange, Juergen Haeussler & Christine Rauschkolb. (2010) Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial. Current Medical Research and Opinion, pages 151-162.
Crossref
Crossref
Perry G. Fine, John Messina, Fang Xie & James Rathmell. (2010) Long-Term Safety and Tolerability of Fentanyl Buccal Tablet for the Treatment of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Pain: An 18-Month Study. Journal of Pain and Symptom Management 40:5, pages 747-760.
Crossref
Crossref
Jennifer P. Schneider, Michele Matthews & Robert N. Jamison. (2010) Abuse-Deterrent and Tamper-Resistant Opioid Formulations. CNS Drugs 24:10, pages 805-810.
Crossref
Crossref
Jaime Calvo-Alén. (2010) Opioids in chronic musculoskeletal conditions. Therapeutic Advances in Musculoskeletal Disease 2:5, pages 291-297.
Crossref
Crossref
Michael P. Nett. (2010) Postoperative Pain Management. Orthopedics 33:9, pages 23-26.
Crossref
Crossref
John T. Farrar, John Messina, Fang Xie & Russell K. Portenoy. (2010) A Novel 12-Week Study, with Three Randomized, Double-Blind Placebo-Controlled Periods to Evaluate Fentanyl Buccal Tablets for the Relief of Breakthrough Pain in Opioid-Tolerant Patients with Noncancer-Related Chronic Pain. Pain Medicine 11:9, pages 1313-1327.
Crossref
Crossref
Joel R. Saper, Alvin E. Lake, Philip A. Bain, Mark J. Stillman, John F. Rothrock, Ninan T. Mathew, Robert L. Hamel, Maureen Moriarty & Gretchen E. Tietjen. (2010) A Practice Guide for Continuous Opioid Therapy for Refractory Daily Headache: Patient Selection, Physician Requirements, and Treatment Monitoring. Headache: The Journal of Head and Face Pain 50:7, pages 1175-1193.
Crossref
Crossref
Andrew R. Moore, Sebastian Straube, Sheena Derry & Henry J. McQuay. (2010) Chronic low back pain analgesic studies – A methodological minefield. Pain 149:3, pages 431-434.
Crossref
Crossref
Bernd Lange, Brigitte Kuperwasser, Akiko Okamoto, Achim Steup, Thomas Häufel, Judy Ashworth & Mila Etropolski. (2010) Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain. Advances in Therapy 27:6, pages 381-399.
Crossref
Crossref
Robert H. Dworkin, Dennis C. Turk, Sarah Peirce-Sandner, Ralf Baron, Nicholas Bellamy, Laurie B. Burke, Amy Chappell, Kevin Chartier, Charles S. Cleeland, Ann Costello, Penney Cowan, Rozalina Dimitrova, Susan Ellenberg, John T. Farrar, Jacqueline A. French, Ian Gilron, Sharon Hertz, Alejandro R. Jadad, Gary W. Jay, Jarkko Kalliomäki, Nathaniel P. Katz, Robert D. Kerns, Donald C. Manning, Michael P. McDermott, Patrick J. McGrath, Arvind Narayana, Linda Porter, Steve Quessy, Bob A. Rappaport, Christine Rauschkolb, Bryce B. Reeve, Thomas Rhodes, Cristina Sampaio, David M. Simpson, Joseph W. Stauffer, Gerold Stucki, Jeffrey Tobias, Richard E. White & James Witter. (2010) Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain 149:2, pages 177-193.
Crossref
Crossref
Roger Chou. (2010) Pharmacological Management of Low Back Pain. Drugs 70:4, pages 387-402.
Crossref
Crossref
M.D. Rodrigo, J. Herrera, C. Busquets, C. del Pozo & M. López. (2010) Intercambiabilidad de opioides y moléculas bioequivalentes. Revista de la Sociedad Española del Dolor 17:2, pages 104-113.
Crossref
Crossref
Fadia Mayyas, Peter Fayers, Stein Kaasa & Ola Dale. (2010) A Systematic Review of Oxymorphone in the Management of Chronic Pain. Journal of Pain and Symptom Management 39:2, pages 296-308.
Crossref
Crossref
Charles E. Argoff. (2010) Clinical Implications of Opioid Pharmacogenetics. The Clinical Journal of Pain 26:Supplement 10, pages S16-S20.
Crossref
Crossref
Oscar A. de Leon-Casasola. (2010) Multimodal, Multiclass, Multidisciplinary Therapy. The Clinical Journal of Pain 26:Supplement 10, pages S1-S2.
Crossref
Crossref
Steve N. Quessy. (2010) Two-stage enriched enrolment pain trials: A brief review of designs and opportunities for broader application. Pain 148:1, pages 8-13.
Crossref
Crossref
M. Marty. (2010) Prise en charge de la lombalgie chronique. EMC - Trait? de m?decine AKOS 5:4, pages 1-7.
Crossref
Crossref
Nathaniel Katz. (2009) Enriched Enrollment Randomized Withdrawal Trial Designs of Analgesics. The Clinical Journal of Pain 25:9, pages 797-807.
Crossref
Crossref
D J Hewitt, R J Hargreaves, S P Curtis & D Michelson. (2009) Challenges in Analgesic Drug Development. Clinical Pharmacology & Therapeutics 86:4, pages 447-450.
Crossref
Crossref
Brian E. McGeeney. (2009) Pharmacological Management of Neuropathic Pain in Older Adults: An Update on Peripherally and Centrally Acting Agents. Journal of Pain and Symptom Management 38:2, pages S15-S27.
Crossref
Crossref
Michael J. Brennan. (2009) Summary of Short-term and Long-term Oxymorphone Efficacy (Pain) Studies in Low Back Pain, Cancer Pain, Osteoarthritis, and Neuropathic Pain. Pain Medicine 10:suppl 1, pages S11-S19.
Crossref
Crossref
Howard S. Smith. (2009) Clinical Pharmacology of Oxymorphone. Pain Medicine 10:suppl 1, pages S3-S10.
Crossref
Crossref
Steven P. Stanos, David A. Fishbain & Scott M. Fishman. (2009) Pain Management with Opioid Analgesics. American Journal of Physical Medicine & Rehabilitation 88:3, pages S69-S99.
Crossref
Crossref
John H. Peniston & Errol Gould. (2009) Oxymorphone extended release for the treatment of chronic low back pain: A retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use. Clinical Therapeutics 31:2, pages 347-359.
Crossref
Crossref
Bruce Nicholson. (2009) Benefits of Extended-Release Opioid Analgesic Formulations in the Treatment of Chronic Pain. Pain Practice 9:1, pages 71-81.
Crossref
Crossref
Richard J. Bodnar. (2008) Endogenous opiates and behavior: 2007. Peptides 29:12, pages 2292-2375.
Crossref
Crossref
Richard Rauck, Tina Ma, Rosemary Kerwin & Harry Ahdieh. (2008) Titration with Oxymorphone Extended Release to Achieve Effective Long-Term Pain Relief and Improve Tolerability in Opioid-Naive Patients with Moderate to Severe Pain. Pain Medicine 9:7, pages 777-785.
Crossref
Crossref
Christopher A. Hulen. (2008) Nonoperative Treatment of Low Back Pain. Seminars in Spine Surgery 20:2, pages 102-112.
Crossref
Crossref
Jerome Schofferman & Daniel Mazanec. (2008) Evidence-informed management of chronic low back pain with opioid analgesics. The Spine Journal 8:1, pages 185-194.
Crossref
Crossref
. (2007) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 16:8, pages i-xii.
Crossref
Crossref
Amol Deshpande, Andrea D Furlan, Angela Mailis-Gagnon, Steven Atlas & Denis Turk. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Keith Aqua, Joseph S. Gimbel, Neil Singla, Tina Ma, Harry Ahdieh & Rosemary Kerwin. (2007) Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: A randomized, double-blind, active- and placebo-controlled, parallel-group trial. Clinical Therapeutics 29:6, pages 1000-1012.
Crossref
Crossref
David R. P. Guay. (2007) <b>Use of Oral Oxymorphone in the Elderly</b>. The Consultant Pharmacist 22:5, pages 417-430.
Crossref
Crossref